BioMarin Pharmaceutical's CEO Discusses Q2 2012 Results - Earnings Call ...

News | 02 August 2012

Results may differ materially depending on the progress of BioMarin's product programs, actions of regulatory authorities, availability of capital, future actions in the pharmaceutical market and developments by competitors, and those factors detailed ...

Click on the link to read the full article at Seeking Alpha
(This link will open in a new window)